2020 annual financial data
Monopar Therapeutics 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was -3,809.05%.
Operating income was -6,508,875 USD and net income was -6,304,573 USD.
Operating cash flow was -4,662,274 USD.
Get free Monopar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 122,400 USD
- Operating income
- -6,508,875 USD
- Net income
- -6,304,573 USD
- Operating cash flow
- -4,662,274 USD